Has the company specifically stated they intend to partner with Big Pharma? I don't recall them having stated the partner would necessarily be a big pharma company, but could instead be someone like ICON, which is not a BP but can certainly handle commercialization of LymPro and allow the company to keep most of the revenue generated, where BP partnership would significantly split the revenue.

It's possible I'm mistaken here, but over the long haul I can remember Gerald mentioning pharma companies in some discussions, but not stating that his goal was to necessarily partner with a BP vs. a lab such as ICON.

Specific references to partnering with BP, please.